| Prevention of HIV-1 infection with early antiretroviral therapy MS Cohen, YQ Chen, M McCauley, T Gamble, MC Hosseinipour, ... New England journal of medicine 365 (6), 493-505, 2011 | 9064 | 2011 |
| A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less SM Hammer, KE Squires, MD Hughes, JM Grimes, LM Demeter, ... New England Journal of Medicine 337 (11), 725-733, 1997 | 3334 | 1997 |
| Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy RM Gulick, JW Mellors, D Havlir, JJ Eron, C Gonzalez, D McMahon, ... New England Journal of Medicine 337 (11), 734-739, 1997 | 2509 | 1997 |
| Antiretroviral therapy for the prevention of HIV-1 transmission MS Cohen, YQ Chen, M McCauley, T Gamble, MC Hosseinipour, ... New England Journal of Medicine 375 (9), 830-839, 2016 | 2000 | 2016 |
| Effect of early versus deferred antiretroviral therapy for HIV on survival MM Kitahata, SJ Gange, AG Abraham, B Merriman, MS Saag, AC Justice, ... New England Journal of Medicine 360 (18), 1815-1826, 2009 | 1636 | 2009 |
| Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy NM Archin, AL Liberty, AD Kashuba, SK Choudhary, JD Kuruc, ... Nature 487 (7408), 482-485, 2012 | 1399 | 2012 |
| Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society–USA panel SM Hammer, JJ Eron, P Reiss, RT Schooley, MA Thompson, S Walmsley, ... Jama 300 (5), 555-570, 2008 | 1299 | 2008 |
| Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America JP Lalezari, K Henry, M O'Hearn, JSG Montaner, PJ Piliero, B Trottier, ... New England Journal of Medicine 348 (22), 2175-2185, 2003 | 1236 | 2003 |
| Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society–USA panel MA Thompson, JA Aberg, JF Hoy, A Telenti, C Benson, P Cahn, JJ Eron, ... Jama 308 (4), 387-402, 2012 | 1162 | 2012 |
| Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1 MS Cohen, IF Hoffman, RA Royce, P Kazembe, JR Dyer, CC Daly, ... The Lancet 349 (9069), 1868-1873, 1997 | 1132 | 1997 |
| Brief but efficient: acute HIV infection and the sexual transmission of HIV CD Pilcher, HC Tien, JJ Eron, PL Vernazza, SY Leu, PW Stewart, LE Goh, ... Journal of infectious diseases 189 (10), 1785-1792, 2004 | 957 | 2004 |
| Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2016 recommendations of the International Antiviral Society–USA panel HF Günthard, MS Saag, CA Benson, C Del Rio, JJ Eron, JE Gallant, ... Jama 316 (2), 191-210, 2016 | 907 | 2016 |
| Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies … GD Tomaras, NL Yates, P Liu, L Qin, GG Fouda, LL Chavez, AC Decamp, ... Journal of virology 82 (24), 12449-12463, 2008 | 858 | 2008 |
| Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2018 recommendations of the International Antiviral Society–USA Panel MS Saag, CA Benson, RT Gandhi, JF Hoy, RJ Landovitz, MJ Mugavero, ... Jama 320 (4), 379-396, 2018 | 735 | 2018 |
| Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter JJ Eron, SL Benoit, J Jemsek, RD MacArthur, J Santana, JB Quinn, ... New England Journal of Medicine 333 (25), 1662-1669, 1995 | 670 | 1995 |
| Cabotegravir for HIV prevention in cisgender men and transgender women RJ Landovitz, D Donnell, ME Clement, B Hanscom, L Cottle, L Coelho, ... New England Journal of Medicine 385 (7), 595-608, 2021 | 668 | 2021 |
| Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial B Grinsztejn, MC Hosseinipour, HJ Ribaudo, S Swindells, J Eron, ... The Lancet infectious diseases 14 (4), 281-290, 2014 | 656 | 2014 |
| Maximizing sensitivity and specificity of PCR by pre-amplification heating. RT D'Aquila, LJ Bechtel, JA Videler, JJ Eron, P Gorczyca, JC Kaplan Nucleic Acids Research 19 (13), 3749, 1991 | 636 | 1991 |
| Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial DA Margolis, J Gonzalez-Garcia, HJ Stellbrink, JJ Eron, Y Yazdanpanah, ... The Lancet 390 (10101), 1499-1510, 2017 | 552 | 2017 |
| Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 recommendations of the International Antiviral Society–USA Panel MS Saag, RT Gandhi, JF Hoy, RJ Landovitz, MA Thompson, PE Sax, ... Jama 324 (16), 1651-1669, 2020 | 515 | 2020 |
